In addition, post-operative bevacizumab treatment showed a trend toward prolonged OS compared with pre-operative bevacizumab treatment.
← all excerpts
The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer.
1
—
—